Boston 3T Biotechnologies Inc.
Boston 3T Biotechnology's technology in development is designed to cure cancer, through the use of therapeutic T Cell technology.
Through our patent pending cancer technologies, we address both the humanitarian as well as the economic issues relating to cancer, both solid, as well as liquid tumors. We have passed the "discovery stage", and are ready to enter the next stage of testing . Our targeted customer will likely be a large pharmaceutical company to partner with Boston 3T Biotechnology through a licensing or sales of our technology.